Multifrequency Magnetic Resonance Elastography Detects Small Abdominal Lymph Node Metastasis by High Stiffness.
Journal
Investigative radiology
ISSN: 1536-0210
Titre abrégé: Invest Radiol
Pays: United States
ID NLM: 0045377
Informations de publication
Date de publication:
02 Jul 2024
02 Jul 2024
Historique:
medline:
1
7
2024
pubmed:
1
7
2024
entrez:
1
7
2024
Statut:
aheadofprint
Résumé
Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 is a clinical and research standard for evaluating malignant tumors and lymph node metastasis. However, quantitative analysis of nodal status is limited to measurement of short axis diameter (SAD), and metastatic lymph nodes below 10 mm in SAD are often not detected. The purpose of this study was to evaluate the value of multifrequency magnetic resonance elastography (MRE) when added to RECIST 1.1 for detection of lymph node metastasis. Twenty-five benign and 82 metastatic lymph nodes were prospectively examined by multifrequency MRE at 1.5 T using tomoelastography postprocessing at 30, 40, 50, and 60 Hz (total scan time of 4 minutes). Shear wave speed as a surrogate of soft tissue stiffness was provided in m/s. Positron emission tomography-computed tomography was used as reference standard for identification of abdominal lymph node metastasis from histologically confirmed primary tumors. The diagnostic performance of MRE was compared with that of SAD according to RECIST 1.1 and evaluated by receiver operating characteristic curve analysis using generalized linear mixed models and binary logistic mixed models. Sensitivity, specificity, and predictive values were calculated for different cutoffs. Metastatic lymph nodes (1.90 ± 0.57 m/s) were stiffer than benign lymph nodes (0.98 ± 0.20 m/s, P < 0.001). An area under the curve of 0.95 for a cutoff of 1.32 m/s was calculated. Using a conservative approach with 1.0 specificity, we found sensitivity (SAD/MRE/MRE + SAD, 0.56/0.84/0.88), negative predictive values (0.41/0.66/0.71), and overall accuracy (0.66/0.88/0.91) to be improved using MRE and even higher for combined MRE and SAD. Multifrequency MRE improves metastatic abdominal lymph node detection by 25% based on higher tissue stiffness-even for lymph nodes with an SAD ≤10 mm. Stiffness information is quick to obtain and would be a promising supplement to RECIST.
Identifiants
pubmed: 38948965
doi: 10.1097/RLI.0000000000001089
pii: 00004424-990000000-00228
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: I.S. is patent holder to a technical development related to magnetic resonance elastography. All the other authors declare no potential conflicts of interest.
Références
Scheenen TWJ, Zamecnik P. The role of magnetic resonance imaging in (future) cancer staging: note the nodes. Invest Radiol. 2021;56:42–49.
Kwee TC, Basu S, Torigian DA, et al. Defining the role of modern imaging techniques in assessing lymph nodes for metastasis in cancer: evolving contribution of PET in this setting. Eur J Nucl Med Mol Imaging. 2011;38:1353–1366.
Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–247.
Schwartz LH, Bogaerts J, Ford R, et al. Evaluation of lymph nodes with RECIST 1.1. Eur J Cancer. 2009;45:261–267.
Beier M, Sack I, Beck-Broichsitter B, et al. Tomoelastography for non-invasive detection of ameloblastoma and metastatic neck lymph nodes. BMJ Case Rep. 2020;13:e235930.
Marticorena Garcia SR, Zhu L, Gültekin E, et al. Tomoelastography for measurement of tumor volume related to tissue stiffness in pancreatic ductal adenocarcinomas. Invest Radiol. 2020;55:769–774.
Shahryari M, Tzschätzsch H, Guo J, et al. Tomoelastography distinguishes noninvasively between benign and malignant liver lesions. Cancer Res. 2019;79:5704–5710.
Zhu L, Guo J, Jin Z, et al. Distinguishing pancreatic cancer and autoimmune pancreatitis with in vivo tomoelastography. Eur Radiol. 2021;31:3366–3374.
Tzschätzsch H, Guo J, Dittmann F, et al. Tomoelastography by multifrequency wave number recovery from time-harmonic propagating shear waves. Med Image Anal. 2016;30:1–10.
Yushkevich PA, Piven J, Hazlett HC, et al. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage. 2006;31:1116–1128.
Friston KJ, Ashburner J, Frith CD, et al. Spatial registration and normalization of images. Hum Brain Mapp. 1995;3:165–189.
Yoshida Y, Kurokawa T, Kawahara K, et al. Incremental benefits of FDG positron emission tomography over CT alone for the preoperative staging of ovarian cancer. AJR Am J Roentgenol. 2004;182:227–233.
Wang Y, Tang Y, Gao X, et al. Optimization of prostate cancer patient lymph node staging via the integration of neutrophil-lymphocyte ratios, platelet-lymphocyte ratios, and (68) Ga-PSMA-PET-derived SUVmax values. Prostate. 2022;82:1415–1421.
Sugai K, Sekine Y, Kawamura T, et al. Sphericity of lymph nodes using 3D-CT predicts metastasis in lung cancer patients. Cancer Imaging. 2023;23:124.
Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.
Bakdash JZ, Marusich LR. Repeated measures correlation. Front Psychol. 2017;8:456.
Gültekin E, Wetz C, Braun J, et al. Added value of tomoelastography for characterization of pancreatic neuroendocrine tumor aggressiveness based on stiffness. Cancers (Basel). 2021;13:5185.
Li M, Guo J, Hu P, et al. Tomoelastography based on multifrequency MR elastography for prostate cancer detection: comparison with multiparametric MRI. Radiology. 2021;299:362–370.
Pagé G, Tardieu M, Besret L, et al. Assessing tumor mechanics by MR Elastography at different strain levels. J Magn Reson Imaging. 2019;50:1982–1989.
Shi Y, Gao F, Li Y, et al. Differentiation of benign and malignant solid pancreatic masses using magnetic resonance elastography with spin-echo echo planar imaging and three-dimensional inversion reconstruction: a prospective study. Eur Radiol. 2018;28:936–945.
Guo J, Savic LJ, Hillebrandt KH, et al. MR elastography in cancer. Invest Radiol. 2023;58:578–586.
Malhotra D, Fletcher AL, Astarita J, et al. Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks. Nat Immunol. 2012;13:499–510.
Barkovskaya A, Buffone A Jr., Žídek M, et al. Proteoglycans as mediators of cancer tissue mechanics. Front Cell Dev Biol. 2020;8:569377.
Buffone A, Weaver VM. Don't sugarcoat it: how glycocalyx composition influences cancer progression. J Cell Biol. 2020;219:e201910070.
Paszek MJ, Zahir N, Johnson KR, et al. Tensional homeostasis and the malignant phenotype. Cancer Cell. 2005;8:241–254.
Fuhs T, Wetzel F, Fritsch AW, et al. Rigid tumours contain soft cancer cells. Nat Phys. 2022;18:1510–1519.
Driessen D, Zámecnik P, Dijkema T, et al. High-accuracy nodal staging of head and neck cancer with USPIO-enhanced MRI: a new reading algorithm based on node-to-node matched histopathology. Invest Radiol. 2022;57:810–818.
Peng L, Li J, Meng C, et al. Can (68)Ga-prostate specific membrane antigen positron emission tomography/computerized tomography provide an accurate lymph node staging for patients with medium/high risk prostate cancer? A diagnostic meta-analysis. Radiat Oncol. 2020;15:227.
Hövels AM, Heesakkers RA, Adang EM, et al. The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol. 2008;63:387–395.
Hofman MS, Lawrentschuk N, Francis RJ, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2020;395:1208–1216.
Mimoun C, Rouzier R, Benifla JL, et al. Preoperative CT or PET/CT to assess pelvic and para-aortic lymph node status in epithelial ovarian cancer? A systematic review and meta-analysis. Diagnostics (Basel). 2021;11:1748.
Ryu KH, Lee KH, Ryu J, et al. Cervical lymph node imaging reporting and data system for ultrasound of cervical lymphadenopathy: a pilot study. Am J Roentgenol. 2016;206:1286–1291.
Marino MA, Avendano D, Zapata P, et al. Lymph node imaging in patients with primary breast cancer: concurrent diagnostic tools. Oncologist. 2020;25:e231–e242.
Horvat N, Carlos Tavares Rocha C, Clemente Oliveira B, et al. MRI of rectal cancer: tumor staging, imaging techniques, and management. Radiographics. 2019;39:367–387.
Bhutani MS, Hawes RH, Hoffman BJ. A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration for diagnosis of malignant lymph node invasion. Gastrointest Endosc. 1997;45:474–479.
Hu J, Guo J, Pei Y, et al. Rectal tumor stiffness quantified by in vivo tomoelastography and collagen content estimated by histopathology predict tumor aggressiveness. Front Oncol. 2021;11:701336.
Hu B, Deng Y, Chen J, et al. Evaluation of MR elastography for prediction of lymph node metastasis in prostate cancer. Abdom Radiol (NY). 2021;46:3387–3400.
Chami L, Giron A, Ezziane M, et al. Quantitative and qualitative approach for shear wave elastography in superficial lymph nodes. Ultrasound Med Biol. 2021;47:2117–2127.
Lerchbaumer MH, Wakonig KM, Arens P, et al. Quantitative multiparametric ultrasound (mpUS) in the assessment of inconclusive cervical lymph nodes. Cancers (Basel). 2022;14.
Li Z, Gao Y, Gong H, et al. Different imaging modalities for the diagnosis of axillary lymph node metastases in breast cancer: a systematic review and network meta-analysis of diagnostic test accuracy. J Magn Reson Imaging. 2022;57:1392–1403.
Sun Y, Wang W, Mi C, et al. Differential diagnosis value of shear-wave elastography for superficial enlarged lymph nodes. Front Oncol. 2022;12:908085.
Barr RG, Wilson SR, Rubens D, et al. Update to the Society of Radiologists in ultrasound liver elastography consensus statement. Radiology. 2020;296:263–274.
Tenbergen CJA, Fortuin AS, van Asten JJA, et al. The potential of iron oxide nanoparticle-enhanced MRI at 7 T compared with 3 T for detecting small suspicious lymph nodes in patients with prostate cancer. Invest Radiol. 2023.
Czarniecki M, Pesapane F, Wood BJ, et al. Ultra-small superparamagnetic iron oxide contrast agents for lymph node staging of high-risk prostate cancer. Transl Androl Urol. 2018;7(Suppl 4):S453–s61.
Veit P, Ruehm S, Kuehl H, et al. Lymph node staging with dual-modality PET/CT: enhancing the diagnostic accuracy in oncology. Eur J Radiol. 2006;58:383–389.